banner
yourwaycareer

yourwaycareer

yourwaycareer官方网站,分享职业发展的一切~
email
xiaohongshu
facebook
xiaoyuzhou
x
AI Translation
This post is translated from Chinese into English through AI.View Original
cover

Shanghai | Pfizer Internal Medicine and Infectious Diseases Division (I&I) Marketing Intern

- Company Name: Pfizer Inc. - Industry: Pharmaceutical and Biotechnology Industry - Brief History: Pfizer was founded in 1849 in Brooklyn, New York, by Charles Pfizer and Charles Erhart, originally as a fine chemicals company producing products like iodine and tartaric acid. In the 1880s, it shifted to the pharmaceutical field, establishing its position as a global pharmaceutical giant in the 20th century with antibiotics like streptomycin and penicillin. In 2020, Pfizer collaborated with Germany's BioNTech to develop the world's first approved mRNA COVID-19 vaccine (Comirnaty), attracting widespread attention. - Products or Services: Pfizer focuses on the research, production, and commercialization of innovative drugs and vaccines, with core therapeutic areas including oncology, rare diseases, anti-infectives, inflammation and immunology, cardiovascular metabolism, and vaccines. Representative products include the COVID-19 vaccine Comirnaty, antiviral drug Paxlovid, anticoagulant Eliquis, breast cancer drug Ibrance, and the Prevnar series of pneumococcal vaccines. - Key Achievements: Pfizer is one of the highest-grossing pharmaceutical companies globally, with total revenue reaching $58.5 billion in 2024. Its COVID-19 vaccine generated over $36 billion in sales during the peak of the pandemic, setting a record for single drug sales. The company employs over 90,000 people, operates in 175 countries, and continues to invest in research and development—spending over $10 billion on R&D in 2024. With a strong portfolio of patented drugs and a global presence, Pfizer consistently ranks among the Fortune Global 500 and the top three global pharmaceutical companies.
Loading...
Ownership of this page data is guaranteed by blockchain and smart contracts to the creator alone.